INSERT INTO medical_documents (id, title, content, source, topic, url, document_type, category, scraped_date, content_hash, word_count, created_at, embedding_date) VALUES ('af9dde6b848cceaae6b978eaa5c4c1f6', 'Periprosthetic Joint Infection: A Multifaceted Burden Undermining Arthroplasty Success (Part 1)', 'Despite advancements in surgical techniques and implant designs, Periprosthetic joint infection (PJI) continues to be one of the commonest and most devastating causes of failure in total joint arthroplasty. PJIs are associated with significant morbidity and mortality, placing a multifactorial burden on patients, caregivers, surgeons, hospitals, health systems, and economies. The incidence of PJI ranges from 0.5% to 2.3% based on current literature. Mortality rates in PJI subsequent to a primary total hip arthroplasty (THA) range from 4% to 8% after one year. The common treatment for PJI is a two-stage revision THA, which itself is associated with significant morbidity and mortality. The economic burden of PJI is substantial, with treatment costs 3 to 5.6 times higher than primary THA. ated with significant morbidity and mortality. The economic burden of PJI is substantial, with treatment costs 3 to 5.6 times higher than primary THA. Patients with PJI experience inferior hip function, lower health-related quality of life scores, and higher odds of developing new onset depression. PJI’s negatively impacts on a patient’s capacity to work and conduct everyday activities. Orthopaedic surgeons also face significant psychological stress due to the challenges in managing PJI, including feelings of incompetence, insecurity, and frustration. Continued research and innovation are essential to optimize THA outcomes and reduce the need for revision surgeries. Improved prevention strategies, multidisciplinary cooperation, and comprehensive care for revision surgeries. Improved prevention strategies, multidisciplinary cooperation, and comprehensive care', 'PubMed_Central', 'diabetes management', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC', 'research_abstract', 'scientific_literature', '2025-06-26T12:59:37.912895', 'bad8b27de54b0cbdf7b6306e7ba3fd06', 0, '2025-06-26T13:08:06.439771', '2025-06-26T13:08:06.439772');
INSERT INTO medical_documents (id, title, content, source, topic, url, document_type, category, scraped_date, content_hash, word_count, created_at, embedding_date) VALUES ('a20fa629303b0c83e6ebd38f075dc8a0', 'Periprosthetic Joint Infection: A Multifaceted Burden Undermining Arthroplasty Success (Part 2)', 'stress due to the challenges in managing PJI, including feelings of incompetence, insecurity, and frustration. Continued research and innovation are essential to optimize THA outcomes and reduce the need for revision surgeries. Improved prevention strategies, multidisciplinary cooperation, and comprehensive care and support for both patients and surgeons are crucial. It is paramount that every orthopaedic surgeon remains cognisant of this complication to institute better prevention strategies, promote better multi-disciplinary cooperation and enhance patient pre-operative care.', 'PubMed_Central', 'diabetes management', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC', 'research_abstract', 'scientific_literature', '2025-06-26T12:59:37.912895', 'bad8b27de54b0cbdf7b6306e7ba3fd06', 0, '2025-06-26T13:08:06.439792', '2025-06-26T13:08:06.439793');
INSERT INTO medical_documents (id, title, content, source, topic, url, document_type, category, scraped_date, content_hash, word_count, created_at, embedding_date) VALUES ('e09341c3bc0b1c1254673e1a46c02cfe', 'Medicines used in the treatment of opioid dependence (Part 1)', 'Opioid dependence is a chronic condition that can lead to significant harm if left untreated. People who experience opioid dependence and the treatments themselves are highly stigmatised. Person-centred trauma-informed services are critical to therapeutic engagement and effectiveness. Buprenorphine and methadone are highly effective, evidence-based medicines for opioid dependence. In recent years, long-acting injectable buprenorphine has emerged as a safe and effective treatment option, offering flexible weekly or monthly dosing. The long-term treatment of opioid dependence can be undertaken in primary care settings. General practitioner and nurse practitioner prescribing, and community pharmacist dispensing, are essential for ongoing care. n primary care settings. General practitioner and nurse practitioner prescribing, and community pharmacist dispensing, are essential for ongoing care. Australian jurisdictions have differing regulations that guide the prescribing of medicines for opioid dependence. Health professionals should be familiar with their local jurisdiction’s guidelines as well as the national guidelines. Drug and alcohol telephone services are available in each jurisdiction and can provide advice to health professionals.', 'PubMed_Central', 'diabetes management', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC', 'research_abstract', 'scientific_literature', '2025-06-26T12:59:37.912943', '05fe99b8976fb8800d5a33ee18e351cb', 0, '2025-06-26T13:08:06.439801', '2025-06-26T13:08:06.439802');
INSERT INTO medical_documents (id, title, content, source, topic, url, document_type, category, scraped_date, content_hash, word_count, created_at, embedding_date) VALUES ('8b26552a64e5af970f5f325c543ffa82', 'High prevalence of unrecognized chronic kidney disease in the Lolland-Falster Health Study: a population-based study in a rural provincial area of Denmark (Part 1)', 'Chronic kidney disease (CKD) affects 10–15% globally and is a marked independent risk factor for cardiovascular disease. Prevalence estimations are essential for public health planning and implementation of CKD treatment strategies. This study aimed to estimate the prevalence and stages of CKD in the population-based Lolland-Falster Health Study, set in a rural provincial area with the lowest socioeconomic status in Denmark. Additionally, the study characterized participants with CKD, evaluated the overall disease recognition, including the awareness of CKD and compared it with other common conditions. Cross-sectional data were obtained from clinical examinations, biochemical analyses, and questionnaires. and compared it with other common conditions. Cross-sectional data were obtained from clinical examinations, biochemical analyses, and questionnaires. CKD was defined as albuminuria (urine albumin–creatinine ratio ≥30 mg/g), estimated glomerular filtration rate (eGFR) <60 ml/min/1.73 m², or by a diagnosis in the National Patient Register. Patient awareness was assessed by self-reported CKD, and overall disease recognition by either a registered hospital diagnosis or self-reported CKD. Among 16 097 adults (median age 58.6 years), CKD prevalence was 18.0% (n = 2903), with 70.1% identified by albuminuria, 28.4% by reduced eGFR, and 1.5% by a registered diagnosis alone. Of those with CKD, 98.8% had stages 1–3 (eGFR ≥30 ml/min/1.73 m²), and 1.2% had stages 4–5 (eGFR <30 ml/min/1.73 m²). by a registered diagnosis alone. Of those with CKD, 98.8% had stages 1–3 (eGFR ≥30 ml/min/1.73 m²), and 1.2% had stages 4–5 (eGFR <30 ml/min/1.73 m²). Female sex, comorbidities, smoking, and', 'PubMed_Central', 'diabetes management', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC', 'research_abstract', 'scientific_literature', '2025-06-26T12:59:37.912972', 'c2a08a39e474f70177141a582a325857', 0, '2025-06-26T13:08:06.439817', '2025-06-26T13:08:06.439819');
INSERT INTO medical_documents (id, title, content, source, topic, url, document_type, category, scraped_date, content_hash, word_count, created_at, embedding_date) VALUES ('78d61ae2a7bb9895fc462031e36877dd', 'High prevalence of unrecognized chronic kidney disease in the Lolland-Falster Health Study: a population-based study in a rural provincial area of Denmark (Part 2)', 'identified by albuminuria, 28.4% by reduced eGFR, and 1.5% by a registered diagnosis alone. Of those with CKD, 98.8% had stages 1–3 (eGFR ≥30 ml/min/1.73 m²), and 1.2% had stages 4–5 (eGFR <30 ml/min/1.73 m²). Female sex, comorbidities, smoking, and low socioeconomic parameters were independently associated with CKD. Patient awareness of CKD was 4.4%, compared to >50% for hypertension and >80% for diabetes, and the overall CKD recognition (self-reported or registered diagnosis) was 7.1%. Thus, in this population-based study, CKD was highly prevalent but poorly recognized, indicating great potential for preventing CKD progression and related complications.', 'PubMed_Central', 'diabetes management', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC', 'research_abstract', 'scientific_literature', '2025-06-26T12:59:37.912972', 'c2a08a39e474f70177141a582a325857', 0, '2025-06-26T13:08:06.439838', '2025-06-26T13:08:06.439839');
INSERT INTO medical_documents (id, title, content, source, topic, url, document_type, category, scraped_date, content_hash, word_count, created_at, embedding_date) VALUES ('f89b8693d04b4e37de143241732c0bac', 'Psoriasis: an update on topical and systemic therapies', 'Psoriasis is an immune-mediated inflammatory disease with a genetic predisposition. Although manifesting predominantly as a hyperproliferative skin disorder, psoriasis is a systemic disease associated with a range of comorbidities including arthritis, cardiovascular disease and depression. Educating the patient that psoriasis is chronic and that there are possible comorbidities is paramount. Patients with a limited number of plaques and no systemic symptoms may be managed with intermittent use of topical therapies. Those with more extensive or debilitating disease may require phototherapy or systemic medicines such as methotrexate or one of the newer targeted therapies. ith more extensive or debilitating disease may require phototherapy or systemic medicines such as methotrexate or one of the newer targeted therapies. Newer systemic therapies, including oral medicines and injectable biologics, can only be used following unsuccessful treatment with traditional therapies such as methotrexate and phototherapy. Biologic therapies for psoriasis offer the possibility of near-complete symptom resolution in people with psoriatic disease.', 'PubMed_Central', 'mental health treatment', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC', 'research_abstract', 'scientific_literature', '2025-06-26T12:59:40.860901', 'b7715f36d433bcb22c8e4d43c717b17f', 0, '2025-06-26T13:08:06.439847', '2025-06-26T13:08:06.439848');
INSERT INTO medical_documents (id, title, content, source, topic, url, document_type, category, scraped_date, content_hash, word_count, created_at, embedding_date) VALUES ('74c6da68b5927a4b0ba8e3ed5734e4e5', 'Relationship between the weight-adjusted-waist index and urinary incontinence in women: A cross-sectional study of NHANES 2007 to 2020 (Part 1)', 'This study investigated the relationship between the weight-adjusted-waist index (WWI), calculated as waist circumference (WC) divided by the square root of weight, and the risk of 3 types of urinary incontinence (UI) in women. Data from the National Health and Nutrition Examination Survey spanning 2007 to 2020 were analyzed, including 7236 female participants aged 20 years and older. UI types (stress UI [SUI], urgency UI [UUI], and mixed UI [MUI]) were classified based on self-reported questionnaires. Multivariate logistic regression models were used to assess the association between WWI and UI, adjusting for covariates such as age, race, marital status, education level, and comorbidities. ere used to assess the association between WWI and UI, adjusting for covariates such as age, race, marital status, education level, and comorbidities. Subgroup analyses were conducted to evaluate the consistency of associations across different age groups, body mass index (BMI) categories, and racial backgrounds. Additionally, dose–response relationships were examined, and receiver operating characteristic curve analysis was performed to compare the predictive ability of WWI, BMI, and WC for UI. The results revealed that the prevalence rates of SUI, UUI, and MUI were 47.55%, 29.09%, and 18.14%, respectively. Higher WWI was significantly associated with increased risks of all 3 UI types. In the fully adjusted model (Model 4), the odds ratios for SUI, UUI, and MUI were 1.28 (95% confidence iated with increased risks of all 3 UI types. In the fully adjusted model (Model 4), the odds ratios for SUI, UUI, and MUI were 1.28 (95% confidence', 'PubMed_Central', 'nutrition guidelines', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC', 'research_abstract', 'scientific_literature', '2025-06-26T12:59:43.260193', 'c5aa1759d522c37196c8c54607063c84', 0, '2025-06-26T13:08:06.439861', '2025-06-26T13:08:06.439862');
INSERT INTO medical_documents (id, title, content, source, topic, url, document_type, category, scraped_date, content_hash, word_count, created_at, embedding_date) VALUES ('5e06744316e4875b395b9b603bca9967', 'Relationship between the weight-adjusted-waist index and urinary incontinence in women: A cross-sectional study of NHANES 2007 to 2020 (Part 2)', 'and MUI were 47.55%, 29.09%, and 18.14%, respectively. Higher WWI was significantly associated with increased risks of all 3 UI types. In the fully adjusted model (Model 4), the odds ratios for SUI, UUI, and MUI were 1.28 (95% confidence interval [CI]: 1.18–1.37), 1.17 (95% CI: 1.08–1.28), and 1.23 (95% CI: 1.13–1.34), respectively. Subgroup analyses confirmed consistent associations across various demographic and clinical subgroups. Receiver operating characteristic curve analysis demonstrated that WWI had superior discrimination ability compared to BMI and WC, with higher area under the curve (AUC) values for SUI (AUC = 0.601), UUI (AUC = 0.630), and MUI (AUC = 0.628). ination ability compared to BMI and WC, with higher area under the curve (AUC) values for SUI (AUC = 0.601), UUI (AUC = 0.630), and MUI (AUC = 0.628). In conclusion, this study highlights a significant association between higher WWI and increased risks of SUI, UUI, and MUI in women. WWI may serve as a more effective anthropometric indicator for assessing UI risk compared to traditional measures like BMI and WC, offering potential utility in clinical and public health settings for identifying individuals at higher risk of UI and guiding targeted prevention strategies.', 'PubMed_Central', 'nutrition guidelines', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC', 'research_abstract', 'scientific_literature', '2025-06-26T12:59:43.260193', 'c5aa1759d522c37196c8c54607063c84', 0, '2025-06-26T13:08:06.439882', '2025-06-26T13:08:06.439883');
INSERT INTO medical_documents (id, title, content, source, topic, url, document_type, category, scraped_date, content_hash, word_count, created_at, embedding_date) VALUES ('c9bb227b8be1de39c2fe38b50b0e4b16', 'Remote Monitoring of Amyotrophic Lateral Sclerosis Using Digital Health Technologies (Part 1)', 'Current care and research pathways for amyotrophic lateral sclerosis (ALS) primarily rely on regularly scheduled visits to specialized centers. These visits provide intermittent clinical information to health care professionals and require patients to travel to the clinic. Digital health technologies enable continuous data collection directly from the patient''s home, bringing new opportunities for personalized, timely care and a refined assessment of disease severity in clinical trials. In this review, we summarize the state of the art in digital health technologies for remote monitoring of patients with ALS, ranging from televisits through videoconferencing to sensor-based wearable devices. We explore how these technologies can benefit clinical care and advance treatment development. ugh videoconferencing to sensor-based wearable devices. We explore how these technologies can benefit clinical care and advance treatment development. Despite significant progress, real-world adoption of these technologies remains limited. An overview is provided of the key barriers hindering their widespread implementation and the opportunities to advance the field. Significantly, there is an urgent need for harmonization across stakeholders through consensus guidelines and consortia. These efforts are essential to accelerate progress and harness the full potential of digital health technologies to better meet the needs of patients.', 'PubMed_Central', 'exercise therapy', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC', 'research_abstract', 'scientific_literature', '2025-06-26T12:59:44.559579', '841e3298f481c134652bc294b4374d93', 0, '2025-06-26T13:08:06.439897', '2025-06-26T13:08:06.439898');
INSERT INTO medical_documents (id, title, content, source, topic, url, document_type, category, scraped_date, content_hash, word_count, created_at, embedding_date) VALUES ('1f10f1b15cf4d998845c9f901a0a8220', 'Increasing incidence and prevalence of Hodgkin’s lymphoma in Finland: a population-based registry study (Part 1)', 'Hodgkin’s lymphoma (HL) is a lymphoid malignancy with an emphasized incidence in developed countries. This study aimed to assess the changes in the epidemiology of HL in Finland at the population level by utilizing data from six nationwide healthcare registries. A total of 2912 patients with HL, diagnosed and treated between 2000 and 2019 were matched by controls and divided into younger (<50 years) and older cohorts (≥50 years) for analysis. A slightly increasing trend in incidence per age group was observed. For the younger patients, the mean annual incidence was 3.19 for males and 2.89 for females. For the older patients, it was 3.07 and 1.59, respectively. r the younger patients, the mean annual incidence was 3.19 for males and 2.89 for females. For the older patients, it was 3.07 and 1.59, respectively. Finland has higher incidence rates than other Scandinavian countries possibly due to unique human leucocyte antigen allele distribution. There was a notable increase in prevalence. For females, this was particularly emphasized between the ages of 30–50 years, while among males, it was more evenly distributed across all ages. As a result of improved disease management, the proportion of HL survivors is increasing.', 'PubMed_Central', 'hypertension management', 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC', 'research_abstract', 'scientific_literature', '2025-06-26T12:59:46.289634', '4c9d2565c4e1c810cb85e752cc0b25ea', 0, '2025-06-26T13:08:06.439912', '2025-06-26T13:08:06.439913');